- Home
- MYGN vs NARI Comparison
MYGN vs NARI Comparison
Compare MYGN & NARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- NARI
- Stock Information
- Founded
- MYGN 1991
- NARI 2011
- Country
- MYGN United States
- NARI United States
- Employees
- MYGN N/A
- NARI N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NARI Medical/Dental Instruments
- Sector
- MYGN Health Care
- NARI Health Care
- Exchange
- MYGN Nasdaq
- NARI Nasdaq
- Market Cap
- MYGN 2.2B
- NARI 2.6B
- IPO Year
- MYGN 1995
- NARI 2020
- Fundamental
- Price
- MYGN $26.43
- NARI $41.61
- Analyst Decision
- MYGN Buy
- NARI Buy
- Analyst Count
- MYGN 12
- NARI 10
- Target Price
- MYGN $28.18
- NARI $58.63
- AVG Volume (30 Days)
- MYGN 651.3K
- NARI 853.2K
- Earning Date
- MYGN 11-04-2024
- NARI 10-30-2024
- Dividend Yield
- MYGN N/A
- NARI N/A
- EPS Growth
- MYGN N/A
- NARI N/A
- EPS
- MYGN N/A
- NARI N/A
- Revenue
- MYGN $802,200,000.00
- NARI $547,474,000.00
- Revenue This Year
- MYGN $13.84
- NARI $24.02
- Revenue Next Year
- MYGN $9.57
- NARI $18.26
- P/E Ratio
- MYGN N/A
- NARI N/A
- Revenue Growth
- MYGN 14.78
- NARI 24.67
- 52 Week Low
- MYGN $13.82
- NARI $36.73
- 52 Week High
- MYGN $29.30
- NARI $69.40
- Technical
- Relative Strength Index (RSI)
- MYGN 44.56
- NARI 41.22
- Support Level
- MYGN $25.90
- NARI $39.76
- Resistance Level
- MYGN $27.55
- NARI $42.63
- Average True Range (ATR)
- MYGN 0.88
- NARI 1.81
- MACD
- MYGN -0.07
- NARI -0.03
- Stochastic Oscillator
- MYGN 15.59
- NARI 27.17
About MYGN Myriad Genetics Inc.
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.
About NARI Inari Medical Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.